Navigation Links
Working of Drug Department on Hold Without Drug Analyst
Post Your Comments:
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
(Date:12/4/2009)Dental tourism is a phenomenon that was started by people that were looking for an alternative to the high price of dental work in the US, Canada, and other countries. In their search for lower priced
Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3
...n Ignagni, President and CEO of America,s Health I...ay on the cost containment framework presented to ... join with leading stakeholders to help advance a ...ness of our country. We strongly believe that all ...
...announced today that it is partnering with the Cit...ad of H1N1 and other viruses. In support of protec...ing gel at more than 400 new sanitizing stations t...o Department of Public Health for their leadership...
...ersity of Queensland in Australia have found a tra...he South Pacific, to be safe and effective in redu...in the Springer journal Psychopharmacology , the ...a was prescribed in the form of tablets. , Lead ...
... Derma Sciences, Inc. (OTC Bulletin Board: DSC...nounced plans to release its first quarter 2009 re...Company will hold a conference call that same day ... to access the call. You may also access this call...
...s(TM) secures 24/7 physician access to serve offsh...N, May 11 InPlace Medical Solutions, the first fu...lemedicine, has achieved another first in the offs...cy medicine and internal medicine physicians who a...
...1 Bill Carlson, vice president, marketing for GHX... Executive magazine,s 2009 Pros to Know for his c...chain in healthcare. With more than 20 years exper...est and fastest-growing expense category for most ...
Other Medicine News:Health News:AHIP Statement on Cost Containment Framework 2Health News:Harris Joins City of Chicago in Support of Maintaining Good Health Habits 2Health News:Research finds kava safe and effective 2Health News:Derma Sciences Announces Date of Its First Quarter 2009 Earnings Release and Conference Call 2Health News:The Doctor Is In, Around the Clock 2Health News:The Doctor Is In, Around the Clock 3Health News:GHX Vice President Bill Carlson Named to Supply & Demand Chain Executive's 2009 Pros to Know List 2
(Date:12/4/2009)Workers Ensure Emergency Deliveries are Transported ,, PHILADELPHIA, Dec. 4 Teamster members employed by the Philadelphia chapter of the American Red Cross are hard at work educating the public abo
(Date:12/4/2009)SALT LAKE CITY, Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ) announced it has signed a sole-source vendor agreement to provide therapy equipment and rehab supplies to Benchmark Physical Therapy wi
(Date:12/4/2009)LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL V
Breaking Medicine Technology:Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Researchers design new graphene based nano material with magnetic properties 13810 1Researchers design new graphene based nano material with magnetic properties 13810 2BPA Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics Free Babies and Toddlers Act 28SB 797 29 56093 1BPA Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics Free Babies and Toddlers Act 28SB 797 29 56093 2BPA Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics Free Babies and Toddlers Act 28SB 797 29 56093 3BPA Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics Free Babies and Toddlers Act 28SB 797 29 56093 4Pew poll 3A 9 in 10 Iowa voters support more government oversight of food 56091 1Pew poll 3A 9 in 10 Iowa voters support more government oversight of food 56091 2
...ct. 30 Schering-Plough Corp.,and the European Org...,(EORTC) announced long-term follow-up results fro...RTC and the National Cancer Institute of Canada,(N...emotherapy,(temozolomide) Capsules and radiation t...s with glioblastoma multiforme (GBM) versus radiat...
...d Screening Agreement Fuels Discovery of Novel Com...atives with PF-3512676 -, WELLESLEY, Mass., Oct. ...Y ), a biopharmaceutical company,discovering and d...s TLR,Therapeutics(TM), announced today that Pfize...er, has nominated a second TLR9 agonist compound,d...
Other Medicine Technology:Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme 2Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme 3Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme 4Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme 5Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development 2Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development 3
Microalbumin Linearity Control
Total IgE Control
Lyophilized Lipid Control
High-sensitive CRP Control
Medicine Products: